The microcarrier market is expected to witness a CAGR of 5.8% over the forecast period. A microcarrier is a support matrix, which allows the growth of adherent cells in bioreactors. In the large-scale commercial production of biologics and vaccines, microcarriers are employed to grow virus-generating or protein-producing adherent cell populations. As per the scope of the report, microcarrier market includes various equipment and consumables, such as bioreactors, reagents, cell counters, and culture vessels in addition to microcarrier beads.
Rapid Growth of Biologics and Biosimilar Industry is Supplementing the Market Growth
A biological drug, or biologic, is a therapeutic preparation, such as a drug or a vaccine, which is made up of complex biomolecules. They may be composed of proteins or their constituent amino acid, carbohydrates, nucleic acids, or combinations of these substances. Biologics represent a growth market whose revenue has increased by 70% during the period of 2011-2016, and has reached an excess of USD 240 billion. Nearly a quarter of the current biologic pipeline is targeting the indications, which are small molecule dominated and have a large patient pool. This represents the trend of biologics entering non-traditional biologic disease areas, which could benefit from the increased therapeutic efficacy. Furthermore, this is also providing the room to the biosimilar market to grow, despite it cannibalizing the sales of off-patent biologics. In terms of medical efficacy, therapeutic spread, and population access biopharmaceuticals have vast potential, and much of this potential is still untapped. This potential can gradually be realized as manufacturing technologies, such as microcarrier based synthesis make progress, which may lead to commercialization of more effective therapies, increased manufacturing efficacy, and reduced therapy costs. Other factors which are contributing to the market growth include rising demand for cell-based vaccines and therapeutics, and increasing R&D, and the availability of funding for cell therapy research.
High Cost of Biologics and Cell-based Therapies Is Hindering the Market Growth
Due to the complex and poorly defined structure of molecules gaining regulatory approvals, in case of biologics, it is challenging and resource intensive. Similarly, in the case of cell therapies, the development and market introduction costs are much higher than that of small molecules, owing to its stringent clinical trial requirements and the need for more sophisticated manufacturing facilities. These costs essentially result in inflated prices of the therapies at the patient end. Across the globe the cost of biologics and cell-based therapies remain high, for example, the per-patient annual cost of some biologic medications, such as Vimizim (elosulfase alfa), and Soliris (eculizumab) exceed USD 250,000. Similarly, the average cost of stem cell therapy is around USD 5,000 to USD 8,000 per treatment, and in the United States, the stem cell treatments can cost from USD 25,000 to 40,000. The microcarriers are used heavily in the manufacturing and development of biologics and cell therapies, and the high cost of these therapies can potentially hinder the expansion of microcarrier market during the forecast period. Other factors which can potentially impede the market growth include lack of skilled personnel.
North America Dominates the Microcarrier Market
In 2017, North America was the largest regional market in terms of revenue. Sustained growth in pharmaceutical and biotechnology industries, increasing incidence of cancers and other chronic diseases, and a strong trend of R&D investments in life sciences by both industry and academia are primary factors driving the growth of the market.
Key Developments in the Microcarrier Market
- Feb 2018: Corning and CytoSMART announce agreement for cell counting device. Corning to become exclusive supplier of CytoSMART’s new cell counter.
Major Players: Becton, Dickinson and Company, Corning Inc., Danaher Corporation, Eppendorf AG, GE Healthcare, Lonza Group AG, Merck KGaA, Sartorius AG, and Thermo Fisher Scientific Inc. among others
Microcarrier Market Report Summary
More than 5.8%
Feb 2018: Corning and CytoSMART announce agreement for cell counting device, Corning to become exclusive supplier of CytoSMART’s new cell counter.
Becton, Dickinson and Company, Corning Inc., Danaher Corporation, Eppendorf AG, Merck KGaA, Sartorius AG, and Thermo Fisher Scientific Inc. among others
Microcarrier Market report offers latest trends, growth prospects, industry competitiveness, major players, value/supply chain, regional market share, and forecast to 2023.
Reasons to Purchase Microcarrier Market
- Analyzing various perspectives of the global Microcarrier Market with the help of Porter’s five forces analysis
- The segment that is expected to dominate the market
- Regions that are expected to witness fastest growth during the forecast period
- Identify the latest developments, market shares, and strategies employed by the major market players
- 3-month analyst support, along with the Market Estimate sheet (in Excel)
Customization of the Microcarrier Market
- This report can be customized to meet your requirements. Please connect with our representative who will ensure that you get a report that suits your needs.
1.1 Market Definition
2. Research Methodology
3. Executive Summary
4. Key Inferences
5. Market Overview
5.1 Current Market Scenario
5.2 Porter's Five Forces Analysis
5.2.1 Bargaining Power of Suppliers
5.2.2 Bargaining Power of Consumers
5.2.3 Threat of New Entrants
5.2.4 Threat of Substitute Product and Services
5.2.5 Competitive Rivalry Within the Industry
6. Market Dynamics
6.1.1 Rising Demand for Cell-based Vaccines and Therapeutics
6.1.2 Rapid Growth of Biologics and Biosimilar Industry
6.1.3 Increasing R&D and Availability of Funding for Cell Therapy Research
6.2.1 High Cost of Biologics and Cell-based Therapies
6.2.2 Growth Limitations of High Density Microcarrier Cultures
6.4 Key Challenges
7. Market Segmentation
7.1 By Products
22.214.171.124 Cell Counters
126.96.36.199 Culture Vessels
188.8.131.52 Filtration Systems
184.108.40.206 Other Equipments
220.127.116.11 Microcarrier Beads
18.104.22.168.1 Cationic Microcarriers
22.214.171.124.2 Collagen-coated Microcarriers
126.96.36.199.3 Other Microcarrier Beads
7.2 By Application
7.2.1 Cell Therapy
7.2.2 Vaccine Manufacturing
7.2.3 Biologics Manufacturing
7.2.4 Other Applications
7.3 By Geography
7.3.1 North America
188.8.131.52 United States
184.108.40.206 United Kingdom
220.127.116.11 Rest of Europe
18.104.22.168 South Korea
22.214.171.124 Rest of Asia-Pacific
7.3.4 Middle East & Africa
126.96.36.199 South Africa
188.8.131.52 Rest of the Middle East & Africa
7.3.5 South America
184.108.40.206 Rest of South America
8. Key Players and Competitive Landscape
8.1 Becton, Dickinson and Company
8.2 Corning Inc.
8.3 Danaher Corporation
8.4 Eppendorf AG
8.5 GE Healthcare
8.6 Lonza Group AG
8.7 Merck KGaA
8.8 Sartorius AG
8.9 Thermo Fisher Scientific Inc.
*List not Exhaustive
9. Future of the Market